Literature DB >> 32295789

Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19.

Chenyang Lu1, Shasha Li2, Yi Liu3.   

Abstract

Entities:  

Keywords:  antirheumatic agents; cytokines; inflammation

Mesh：

Year:  2020        PMID： 32295789     DOI： 10.1136/annrheumdis-2020-217460

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  14 in total

1.  Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience.

Authors:  Hakan Apaydin; Abdulsamet Erden; Serdar C Güven; Berkan Armağan; Özlem Karakaş; Bahar Özdemir; Bünyamin Polat; Mehmet Akif Eksin; Ahmet Omma; Orhan Kucuksahin
Journal:  Future Virol       Date:  2022-06-15       Impact factor: 3.015

2.  COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database.

Authors:  Amandine Dernoncourt; Jean Schmidt; Pierre Duhaut; Sophie Liabeuf; Valérie Gras-Champel; Kamel Masmoudi; Youssef Bennis; Benjamin Batteux
Journal:  Fundam Clin Pharmacol       Date:  2021-05-25       Impact factor: 2.747

Review 3.  Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.

Authors:  Ilke Coskun Benlidayi; Behice Kurtaran; Emre Tirasci; Rengin Guzel
Journal:  Rheumatol Int       Date:  2020-06-26       Impact factor: 2.631

4.  Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.

Authors:  Alessia Alunno; Francesco Carubbi; Javier Rodríguez-Carrio
Journal:  RMD Open       Date:  2020-05

5.  COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study.

Authors:  Clodoveo Ferri; Dilia Giuggioli; Vincenzo Raimondo; Lorenzo Dagna; Valeria Riccieri; Elisabetta Zanatta; Serena Guiducci; Antonio Tavoni; Rosario Foti; Giovanna Cuomo; Rossella De Angelis; Franco Cozzi; Giuseppe Murdaca; Ilaria Cavazzana; Nicoletta Romeo; Veronica Codullo; Francesca Ingegnoli; Roberta Pellegrini; Giuseppe Varcasia; Alessandra Della Rossa; Maria De Santis; Giuseppina Abignano; Michele Colaci; Maurizio Caminiti; Massimo L'Andolina; Ennio Lubrano; Amelia Spinella; Federica Lumetti; Giacomo De Luca; Silvia Bellando-Randone; Elisa Visalli; Silvia Bilia; Daiana Giannini; Francesco Masini; Greta Pellegrino; Erika Pigatto; Elena Generali; Francesca Dall'Ara; Giuseppa Pagano Mariano; Simone Barsotti; Giorgio Pettiti; Giovanni Zanframundo; Raffaele Brittelli; Vincenzo Aiello; Daniela Scorpiniti; Tommaso Ferrari; Rodolfo Caminiti; Corrado Campochiaro; Salvatore D'Angelo; Florenzo Iannone; Marco Matucci-Cerinic; Andrea Doria; Mario Miccoli; Poupak Fallahi; Alessandro Antonelli
Journal:  Lancet Rheumatol       Date:  2021-01-12

6.  High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.

Authors:  Claudia Diniz Lopes Marques; Adriana Maria Kakehasi; Marcelo Medeiros Pinheiro; Licia Maria Henrique Mota; Cleandro Pires Albuquerque; Carolina Rocha Silva; Gabriela Porfirio Jardim Santos; Edgard Torres Reis-Neto; Pedro Matos; Guilherme Devide; Andrea Dantas; Rina Dalva Giorgi; Adriana de Oliveira Marinho; Lilian David Azevedo Valadares; Ana Karla G Melo; Francinne Machado Ribeiro; Gilda Aparecida Ferreira; Flavia Patricia de Sena Santos; Sandra Lucia Euzebio Ribeiro; Nicole Pamplona Bueno Andrade; Michel Alexandre Yazbek; Viviane Angelina de Souza; Eduardo S Paiva; Valderilio Feijo Azevedo; Ana Beatriz Santos Bacchiega de Freitas; José Roberto Provenza; Ricardo Acayaba de Toledo; Sheilla Fontenelle; Sueli Carneiro; Ricardo Xavier; Gecilmara Cristina Salviato Pileggi; Ana Paula Monteiro Gomides Reis
Journal:  RMD Open       Date:  2021-01

7.  The Impact of COVID-19 Pandemic on the Castile and Leon Addiction Treatment Network: A Real-Word Experience.

Authors:  Carlos Roncero; Begoña Vicente-Hernández; Nerea M Casado-Espada; Lourdes Aguilar; Sinta Gamonal-Limcaoco; María A Garzón; Fernando Martínez-González; Carlos Llanes-Álvarez; Ruth Martínez; Manuel Franco-Martín; Ana Álvarez-Navares
Journal:  Front Psychiatry       Date:  2020-11-25       Impact factor: 4.157

Review 8.  COVID-19 and Disease-Modifying Anti-rheumatic Drugs.

Authors:  Kristin M D'Silva; Zachary S Wallace
Journal:  Curr Rheumatol Rep       Date:  2021-04-24       Impact factor: 4.592

9.  Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.

Authors:  Linh T Bui; Nichelle I Winters; Mei-I Chung; Chitra Joseph; Austin J Gutierrez; Arun C Habermann; Taylor S Adams; Jonas C Schupp; Sergio Poli; Lance M Peter; Chase J Taylor; Jessica B Blackburn; Bradley W Richmond; Andrew G Nicholson; Doris Rassl; William A Wallace; Ivan O Rosas; R Gisli Jenkins; Naftali Kaminski; Jonathan A Kropski; Nicholas E Banovich
Journal:  Nat Commun       Date:  2021-07-14       Impact factor: 14.919

10.  A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study.

Authors:  Claudia Marques; Adriana Maria Kakehasi; Ana Paula Monteiro Gomides; Eduardo Dos Santos Paiva; Edgard Torres Dos Reis Neto; Gecilmara Cristina Salviato Pileggi; José Roberto Provenza; Licia Mota; Gilda Aparecida Ferreira; Marcelo Medeiros Pinheiro; Ricardo Machado Xavier
Journal:  JMIR Res Protoc       Date:  2020-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.